SRC
AGN

Shufro Rose & Co’s Allergan plc AGN Stock Holding History

Shufro Rose & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-105,774
Closed -$18.7M – 312
2020
Q1 		$18.7M Sell
105,774
-1,629
-2% -$307K 2.23% 13
2019
Q4 		$20.5M Sell
107,403
-7,514
-7% -$1.36M 1.85% 17
2019
Q3 		$19.3M Sell
114,917
-1,941
-2% -$316K 1.91% 14
2019
Q2 		$19.6M Sell
116,858
-12,938
-10% -$1.79M 1.9% 12
2019
Q1 		$19M Sell
129,796
-316
-0.2% -$45.8K 1.9% 12
2018
Q4 		$17.4M Sell
130,112
-19,490
-13% -$3.19M 1.92% 12
2018
Q3 		$28.5M Buy
149,602
+460
+0.3% +$84.5K 2.64% 6
2018
Q2 		$24.9M Buy
149,142
+3,050
+2% +$490K 2.38% 7
2018
Q1 		$24.6M Sell
146,092
-344
-0.2% -$57.7K 2.43% 7
2017
Q4 		$24M Buy
146,436
+14,974
+11% +$2.69M 2.36% 7
2017
Q3 		$26.9M Sell
131,462
-23,531
-15% -$5.47M 2.71% 7
2017
Q2 		$37.7M Buy
154,993
+11,198
+8% +$2.63M 4.02% 3
2017
Q1 		$34.4M Buy
143,795
+4,512
+3% +$1.05M 3.71% 3
2016
Q4 		$29.3M Buy
139,283
+1,672
+1% +$346K 3.27% 4
2016
Q3 		$31.7M Buy
137,611
+49,765
+57% +$12.2M 3.54% 4
2016
Q2 		$20.3M Buy
+87,846
New +$20.3M 2.24% 9

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Shufro Rose & Co's AGN Position: Q2 2020 in Review

Shufro Rose & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 105,774 shares — an estimated $18.7M sold.

Shufro Rose & Co first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $37.7M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Shufro Rose & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Shufro Rose & Co sold 105,774 Allergan plc shares in Q2 2020, an estimated $18.7M.
  • Shufro Rose & Co first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • Shufro Rose & Co's Allergan plc position peaked at $37.7M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Shufro Rose & Co's 13F filing for Q2 2020, filed 6 Aug 2020.